Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 3/20 | 0.68 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.68 |
| ▸ | PPARG | P37231 | 3/20 | 0.68 |
| ▸ | PPARD | Q03181 | 3/20 | 0.68 |
| ▸ | PPARA | Q07869 | 3/20 | 0.68 |
| ▸ | TOP1 | P11387 | 3/20 | 0.68 |
| ▸ | MAPT | P10636 | 2/20 | 0.68 |
| ▸ | BLM | P54132 | 2/20 | 0.68 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.68 |
| ▸ | FABP4 | P15090 | 2/20 | 0.68 |
| ▸ | GMNN | O75496 | 1/20 | 0.68 |
| ▸ | USP2 | O75604 | 1/20 | 0.68 |
| ▸ | LMNA | P02545 | 1/20 | 0.68 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.68 |
| ▸ | POLB | P06746 | 1/20 | 0.68 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.68 |
| ▸ | APEX1 | P27695 | 1/20 | 0.68 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.68 |
| ▸ | RECQL | P46063 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11416175 | 1.00 | TERT (0.68) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL9986183 | 1.00 | TERT (0.68) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL5613141 | 0.93 | TERT (0.79) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL11443817 | 0.93 | TERT (0.79) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL11431868 | 0.93 | TERT (0.79) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL11440356 | 0.93 | TERT (0.79) | TERTPTPN1PPARGPPARDPPARA | |
| Erucic Acid SCHEMBL27804948 | 0.93 | TERT (0.79) | TERTPTPN1PPARGPPARDPPARA | |
| Oleic Acid SCHEMBL2386716 | 0.90 | PPARG (0.79) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL3280571 | 0.90 | TERT (0.62) | TERTPTPN1PPARGPPARDPPARA | |
| SCHEMBL7883436 | 0.90 | EPHX2 (0.77) | TERTPTPN1PPARGPPARDPPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10167249-B2 | Amino and imino propionic acids, process of preparation and use | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2019-01-01 | — | — | US | claimed |
| US-10035757-B2 | Amino and imino propionic acids, process of preparation and use | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2018-07-31 | — | — | US | claimed |
| WO-2015059238-A1 | CORROSION INHIBITION OF REINFORCING STEEL EMBEDDED IN A CONCRETE STRUCTURE BY MEANS OF SURFACE APPLICATION OR BY ADDITION OF THE CORROSION-INHIBITING COMPOSITION TO THE FRESH REINFORCED CONCRETE | MAPEI S.P.A. (IT) | 2015-04-30 | — | — | WO | claimed |
| US-20150089861-A1 | AMINO AND IMINO PROPIONIC ACIDS, PROCESS OF PREPARATION AND USE | MEXICANO INST PETROL (MX) | 2015-04-02 | — | — | US | claimed |
| US-20220265857-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS | MODERNATX, INC. (US) | 2022-08-25 | — | — | US | disclosed |
| EP-3386484-B1 | COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS | MODERNATX INC (US) | 2022-03-30 | — | — | EP | disclosed |
| US-11285222-B2 | Compositions and methods for delivery of agents | MODERNATX, INC. (US) | 2022-03-29 | — | — | US | disclosed |
| US-20200206362-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS | Moderna TX, Inc. (US) | 2020-07-02 | — | — | US | disclosed |
| US-10556018-B2 | Compositions and methods for delivery of agents | ARES CAPITAL CORPORATION, AS AGENT | 2020-02-11 | — | — | US | disclosed |
| US-20190117798-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS | MODERNATX, INC. (US) | 2019-04-25 | — | — | US | disclosed |
| US-10207983-B2 | Amino and imino propionic acids, process of preparation and use | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2019-02-19 | — | — | US | disclosed |
| US-10207010-B2 | Compositions and methods for delivery of agents | MODERNATX, INC. (US) | 2019-02-19 | — | — | US | disclosed |
| US-10035757-B2 | Amino and imino propionic acids, process of preparation and use | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2018-07-31 | — | — | US | disclosed |
| US-20180147298-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS | MODERNATX, INC. (US) | 2018-05-31 | — | — | US | disclosed |
| US-20180028664-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS | MODERNATX, INC. (US) | 2018-02-01 | — | — | US | disclosed |
| WO-2017099823-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF THERAPEUTIC AGENTS | MODERNATX, INC. (US) | 2017-06-15 | — | — | WO | disclosed |
| WO-2015059238-A1 | CORROSION INHIBITION OF REINFORCING STEEL EMBEDDED IN A CONCRETE STRUCTURE BY MEANS OF SURFACE APPLICATION OR BY ADDITION OF THE CORROSION-INHIBITING COMPOSITION TO THE FRESH REINFORCED CONCRETE | MAPEI S.P.A. (IT) | 2015-04-30 | — | — | WO | disclosed |
| US-20150112096-A1 | AMINO AND IMINO PROPIONIC ACIDS, PROCESS OF PREPARATION AND USE | MEXICANO INST PETROL (MX) | 2015-04-23 | — | — | US | disclosed |
| US-20150089861-A1 | AMINO AND IMINO PROPIONIC ACIDS, PROCESS OF PREPARATION AND USE | MEXICANO INST PETROL (MX) | 2015-04-02 | — | — | US | disclosed |
| US-20110296746-A1 | Amino and imino propionic acids, process of preparation and use | INSTITUTO MEXICANO DEL PETROLEO (MX) | 2011-12-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (14 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10207983-B2 | Amino and imino propionic acids, process of preparation and use | AADAT, ARNT, AHR | TERT 932/4885PTPN1 3915/4885PPARG 112/4885 |
| US-20190117798-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS | HDLBP, APOB, TSG101 | TERT 2401/4885PTPN1 2571/4885PPARG 3597/4885 |
| US-10035757-B2 | Amino and imino propionic acids, process of preparation and use | AADAT, ARNT, AHR | TERT 932/4885PTPN1 3915/4885PPARG 112/4885 |
| US-10556018-B2 | Compositions and methods for delivery of agents | HDLBP, APOB, TSG101 | TERT 2401/4885PTPN1 2571/4885PPARG 3597/4885 |
| US-20200206362-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS | HDLBP, APOB, TSG101 | TERT 2401/4885PTPN1 2571/4885PPARG 3597/4885 |
| US-10207010-B2 | Compositions and methods for delivery of agents | HDLBP, APOB, TSG101 | TERT 2401/4885PTPN1 2571/4885PPARG 3597/4885 |
| US-11285222-B2 | Compositions and methods for delivery of agents | HDLBP, APOB, TSG101 | TERT 2401/4885PTPN1 2571/4885PPARG 3597/4885 |
| US-20110296746-A1 | Amino and imino propionic acids, process of preparation and use | AADAT, ARNT, AHR | TERT 932/4885PTPN1 3915/4885PPARG 112/4885 |
| US-20220265857-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS | HDLBP, APOB, TSG101 | TERT 2401/4885PTPN1 2571/4885PPARG 3597/4885 |
| US-20150112096-A1 | AMINO AND IMINO PROPIONIC ACIDS, PROCESS OF PREPARATION AND USE | AADAT, ARNT, AHR | TERT 932/4885PTPN1 3915/4885PPARG 112/4885 |
| US-20180147298-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS | HDLBP, APOB, TSG101 | TERT 2401/4885PTPN1 2571/4885PPARG 3597/4885 |
| US-20180028664-A1 | COMPOSITIONS AND METHODS FOR DELIVERY OF AGENTS | HDLBP, APOB, TSG101 | TERT 2401/4885PTPN1 2571/4885PPARG 3597/4885 |
| US-10167249-B2 | Amino and imino propionic acids, process of preparation and use | AADAT, ARNT, AHR | TERT 932/4885PTPN1 3915/4885PPARG 112/4885 |
| US-20150089861-A1 | AMINO AND IMINO PROPIONIC ACIDS, PROCESS OF PREPARATION AND USE | AADAT, ARNT, AHR | TERT 932/4885PTPN1 3915/4885PPARG 112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.